Background To date, standardising clinical predictive biomarkers for assessing the response
to immunotherapy remains challenging due to variations in personal genetic signatures …

Microneedle arrays have recently received much attention as cancer detection and
treatment platforms, because invasive injections and detection of the biopsy are not needed …

Dendritic cell (DC)-based vaccination for cancer treatment has seen considerable
development over recent decades. However, this field is currently in a state of flux toward …

Evidence suggests that increased microRNA-155 (miR-155) expression in immune cells
enhances antitumor immune responses. However, given the reported association of miR …

Next-generation sequencing (NGS) technologies have greatly expanded the size of the
known transcriptome. Many newly discovered transcripts are classified as long noncoding …

Hepatocellular carcinoma (HCC) is the second most lethal cancer and a leading cause of
cancer-related mortality worldwide. Immune checkpoint inhibitors (ICIs) significantly …

Purpose MiR-155 is a member of the microRNAs (miRNAs) family and regulates gene
expression post-transcriptionally by binding to the 3'UTR of target mRNA. MiR-155 has a …

Simple Summary The cross-talk between neoplastic cells and microenvironment is known to
play a crucial role in tumor development as well as in the phenomenon of resistance to …

Simple Summary MiR-155 appears to be a significant regulator of immune responses
against tumors. The aim of this review is to provide an overview of miR-155 function in …

Triple negative breast cancer (TNBC) remains to be a formidable adversary with high
mortality and unfavorable prognosis. Tumor microenvironment comprises of various …